Skip to content
10-Q

Quarterly Report

MAP PHARMACEUTICALS, INC.

0001193125-12-317553

← back to feed
Filed
Jul 27, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Jul 20, 2012 30.75M sh
Capex Q2 2012 · Jun 30, 2012 $1.84M
Capex Q2 2012 · Jun 30, 2012 $16.21M
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$29.43M
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$190.25M
Cash And Equivalents Q2 2012 · Jun 30, 2012 $68.42M
Cash And Equivalents Q2 2012 · Dec 31, 2011 $98.82M
Stockholders Equity Q2 2012 · Jun 30, 2012 $13.61M
Stockholders Equity Q2 2012 · Dec 31, 2011 $39.55M
Current Liabilities Q2 2012 · Jun 30, 2012 $11.33M
Current Liabilities Q2 2012 · Dec 31, 2011 $14.14M
Total Liabilities Q2 2012 · Jun 30, 2012 $62.84M
Total Liabilities Q2 2012 · Dec 31, 2011 $67.79M
Current Assets Q2 2012 · Jun 30, 2012 $69.39M
Current Assets Q2 2012 · Dec 31, 2011 $100.22M
Total Assets Q2 2012 · Jun 30, 2012 $76.45M
Total Assets Q2 2012 · Dec 31, 2011 $107.34M
Sga Expense Q2 2012 · Jun 30, 2012 $6.4M
Sga Expense Q2 2012 · Jun 30, 2012 $14.31M
Sga Expense Q2 2012 · Jun 30, 2012 $99.28M
Rd Expense Q2 2012 · Jun 30, 2012 $7.77M
Rd Expense Q2 2012 · Jun 30, 2012 $18.74M
Rd Expense Q2 2012 · Jun 30, 2012 $269.87M
Net Income Q2 2012 · Jun 30, 2012 −$13.29M
Net Income Q2 2012 · Jun 30, 2012 −$31.14M
Net Income Q2 2012 · Jun 30, 2012 −$291.62M
Operating Income Q2 2012 · Jun 30, 2012 −$13.29M
Operating Income Q2 2012 · Jun 30, 2012 −$31.14M
Operating Income Q2 2012 · Jun 30, 2012 −$290.01M
Revenue Q2 2012 · Jun 30, 2012 $878K
Revenue Q2 2012 · Jun 30, 2012 $1.91M
Revenue Q2 2012 · Jun 30, 2012 $79.14M